棕榈酸帕利哌酮注射液治疗精神分裂症的研究进展
作者：殷莉;黄秀梅;黄颐;
Author：
收稿日期： 年卷（期）页码：2016,31(03):-324-326
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：棕榈酸帕利哌酮;长效注射液;抗精神病药;精神分裂症;有效性;安全性;副反应;作用机制
Key words：
基金项目：
中文摘要
棕榈酸帕利哌酮是一种新型的治疗精神分裂症的长效制剂,具有安全有效、使用方便、患者依从性高等优点。现综述棕榈酸帕利哌酮治疗精神分裂症的疗效、安全性、作用机制及使用方法的研究进展。
参考文献
[1]Kane JM.Pharmacologic treatment of schizophrenia[J].Biol Psychiatry,1999,46:1396-1408.
[2]González-Rodríguez A,Catalán R,Penadés R,et al.Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia:Long-term safety,efficacy,and patient acceptability-a review[J].Patient Prefer Adherence,2015,25:695-706.
[3]张鸿燕,黄继忠,司天梅,等.棕榈酸帕利哌酮临床使用指导意见[J].中国新药杂志,2014,23:1410-1417.
[4]Samtani MN,Gopal S,Gassmann-Mayer C,et al.Dosing and switching strategies for Paliperidone palmitate:Based on population pharmacokinetic modelling and clinical trial data[J].CNS Drugs,2011,25:829-845.
[5]李丹檬,宓为峰,李玲芝,等.帕利哌酮棕榈酸盐多次给药的稳态血药浓度与临床安全性的研究[J].中国临床药理学杂志,2012,28:563-565.
[6]苏芬丽,周志凌,李焕德.HPLC-MS法检测利培酮与9-羟利培酮的血浆浓度及在临床药动学的应用[J].药物分析杂志,2006,26:207-211.
[7]Bossie CA,Sliwa JK,Ma YW,et al.Onset of efficacy and tolerability following the initiation dosing of long-acting Paliperidone palmitate:Post-hoc analyses of a randomized,double-blind clinical trial[J].BMC Psychiatry,2011,10:79-81.
[8]Pandina G,Lane R,Gopal S,et al.A double-blind study of Paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia[J].Prog Neuropsychopharmacol Biol Psychiatry,2011,35:218-226.
[9]Coppola D,Liu Y,Gopal S,et al.A one-year prospective study of the safety,tolerability and pharmacokinetics of the highest available dose of Paliperidone palmitate in patients with schizophrenia[J].BMC Psychiatry,2012,28:12-26.
[10]Bossie CA,Fu DJ,Sliwa JK,et al.Tolerability of initiation doses of once-monthly Paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial[J].Ther Adv Psychopharmacol,2011,1:111-124.
[11]Alphs L,Bossie CA,Sliwa JK,et al.Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia:Post hoc analysis of a randomized,double-blind clinical trial[J].Ann Gen Psychiatry,2011,10:12-14
[12]杨逢润,郭娟.棕榈酸帕利哌酮与利培酮长效针剂治疗精神分裂症的对照研究[J].临床精神医学杂志,2014,24:271.
[13]Fu DJ,Bossie CA,Kern Sliwa J,et al.Paliperidone palmitate versus risperidone long-acting injection in markedly-toseverely ill schizophrenia subjects:Onset of efficacy with recommended initiation regimens[J].Clin Schizophr Relat Psychoses,2014,8:101-109.
[14]Zhang F,Si T,Chiou CF,et al.Efficacy,safety,and impact on hospitalizations of Paliperidone palmitate in recent-onset schizophrenia[J].Neuropsychiatr Dis Treat,2015,11:657-668.
[15]Schreiner A,Bergmans P,Cherubin P,et al.A prospective flexible-dose study of Paliperidone palmitate in nonacute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral antipsychotic agents[J].Clin Ther,2014,36:1372-1388.
[16]Hough D,Gopal S,Vijapurkar U,et al.Paliperidone palmitate maintenance treatment in delaying the time-torelapse in patients with schizophrenia:A randomized,double-blind,placebocontrolled study[J].Schizophr Res,2010,116:107-117.
[17]Alphs L,Mao L,Rodriguez SC,et al.Design and rationale of the Paliperidone palmitate research in demonstrating effectiveness(PRIDE)study:A novel comparative trial of once-monthly Paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia[J].J Clin Psychiatry,2014,75:1388-1393.
[18]Nasrallah HA,Gopal S,Gassmann-Mayer C,et al.A controlled,evidence-based trial of Paliperidone palmitate,a long-acting injectable antipsychotic,in schizophrenia[J].Neuropsychopharmacology,2010,35:2072-2082.
[19]Hough D,Lindenmayer JP,Gopal S,et al.Safety and tolerability of deltoid and gluteal injections of Paliperidone palmitate in schizophrenia[J].Prog Neuropsychopharmacol Biol Psychiatry,2009,33:1022-1031.
[20]Gopal S,Xu H,Bossie C,et al.Incidence of tardive dyskinesia:A comparison of long-acting injectable and oral Paliperidone clinical trial databases[J].Int J Clin Pract,2014,68:1514-1522.
[21]Fleischhacker WW,Gopal S,Lane R,et al.A randomized trial of Paliperidone palmitate and risperidone long-acting injectable in schizophrenia[J].Int J Neuropsychopharmacol,2012,15:107-118.
[22]潘能荣,黄自勇,李哲.棕榈酸帕利哌酮注射液治疗急性精神分裂症的疗效及安全性研究[J].医学信息,2014,10:87.
[23]Hargarter L,Cherubin P,Bergmans P,et al.Intramuscular longacting Paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics[J].Prog Neuropsychopharmacol Biol Psychiatry,2014,58:1-7.
【关闭】
